Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Angle Plc ADR (ANPCY)

Angle Plc ADR (ANPCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Angle PLC Announces HER2 Presentation at SABCS

WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM

ANPCY : 1.3500 (-8.16%)
AGL : 1.9700 (+4.79%)
ANGLE presents two posters at EACR

PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCE

ANPCY : 1.3500 (-8.16%)
AGL : 1.9700 (+4.79%)
Angle PLC Announces Publication Demonstrates CTC Profiling Potential

PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCER

ANPCY : 1.3500 (-8.16%)
AGL : 1.9700 (+4.79%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)
Angle PLC Announces Result of 2022 Annual General Meeting

GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep

BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP

ANPCY : 1.3500 (-8.16%)
AGL.LN : 9.333 (-4.28%)
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep

BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP

ANPCY : 1.3500 (-8.16%)
AGL.LN : 9.333 (-4.28%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)
Angle PLC Announces Secured Contract From Pharma Services Customer

Additional contract for a new clinical trial

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)
Angle PLC Announces Predicting Immunotherapy Response in SCLC

PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCER

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)

Barchart Exclusives

Elon Musk Didn't Expect Tesla or SpaceX to be Succesful, But He Did It Because They "Were Important Enough to do Anyway"
In a reflection on his entrepreneurial journey, tech magnate Elon Musk offered a glimpse into the mindset that led him to launch two of the world’s most groundbreaking ventures: Tesla and SpaceX. Speaking on his early years of founding these companies, Musk said, “I always have optimism, but I’m realistic.... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar